Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Oct;28(4):443–447. doi: 10.1111/j.1365-2125.1989.tb03525.x

A comparison of the ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops in normal human volunteers.

M R al-Sereiti 1, R L Coakes 1, D P O'Sullivan 1, P Turner 1
PMCID: PMC1379995  PMID: 2590602

Abstract

1. The ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops was compared in nine healthy human volunteers, using non-contact tonometry. 2. Considering all post-dosing measurements compared with placebo and including the baseline values as continuous independent variables, using multiple linear regression analysis, both bromocriptine and timolol had a significant ocular hypotensive effect (P less than 0.0001) in the treated eye with a significant but lesser effect in the contralateral eye. 3. In the concentrations used, timolol was more efficacious than bromocriptine in lowering intraocular pressure (P less than 0.025). 4. Using other forms of vehicles for bromocriptine to improve efficacy and studying the ocular hypotensive effect of topical application of other dopamine-2-receptor agonists such as pergolide and lisuride was suggested.

Full text

PDF
443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Sereiti M. R., Turner P. The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP). Br J Clin Pharmacol. 1989 Feb;27(2):159–163. doi: 10.1111/j.1365-2125.1989.tb05346.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Czarnecki J. S., Pilley S. F., Thompson H. S. The analysis of anisocoria. The use of photography in the clinical evaluation of unequal pupils. Can J Ophthalmol. 1979 Oct;14(4):297–302. [PubMed] [Google Scholar]
  3. Geyer O., Robinson D., Lazar M. Hypotensive effect of bromocriptine in glaucomatous eyes. J Ocul Pharmacol. 1987 Winter;3(4):291–294. doi: 10.1089/jop.1987.3.291. [DOI] [PubMed] [Google Scholar]
  4. Grolman B. A new tonometer system. Am J Optom Arch Am Acad Optom. 1972 Aug;49(8):646–660. doi: 10.1097/00006324-197208000-00005. [DOI] [PubMed] [Google Scholar]
  5. Katz I. M., Hubbard W. A., Getson A. J., Gould A. L. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol. 1976 Jun;15(6):489–492. [PubMed] [Google Scholar]
  6. Lustig A. Verstärkt Bromocriptin die Wirkung augeninnendrucksenkender Mittel? Dtsch Med Wochenschr. 1983 Oct 28;108(43):1656–1657. [PubMed] [Google Scholar]
  7. Mekki Q. A., Hassan S. M., Turner P. Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet. 1983 Jun 4;1(8336):1250–1251. doi: 10.1016/s0140-6736(83)92699-5. [DOI] [PubMed] [Google Scholar]
  8. Mekki Q. A., Turner P. Stimulation of dopamine receptors (type 2) lowers human intraocular pressure. Br J Ophthalmol. 1985 Dec;69(12):909–910. doi: 10.1136/bjo.69.12.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mekki Q. A., Warrington S. J., Turner P. Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels. Lancet. 1984 Feb 4;1(8371):287–288. doi: 10.1016/s0140-6736(84)90162-4. [DOI] [PubMed] [Google Scholar]
  10. Potter D. E., Burke J. A., Chang F. W. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment. Curr Eye Res. 1984 Feb;3(2):307–314. doi: 10.3109/02713688408997214. [DOI] [PubMed] [Google Scholar]
  11. Potter D. E., Burke J. A. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr Eye Res. 1982;2(5):281–288. doi: 10.3109/02713688209000771. [DOI] [PubMed] [Google Scholar]
  12. Potter D. E., Burke J. A. LY141865: a relatively selective DA2 agonist with complex ocular activity. J Ocul Pharmacol. 1988 Spring;4(1):19–28. doi: 10.1089/jop.1988.4.19. [DOI] [PubMed] [Google Scholar]
  13. Potter D. E., Shumate D. J. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function. J Ocul Pharmacol. 1987 Winter;3(4):309–321. doi: 10.1089/jop.1987.3.309. [DOI] [PubMed] [Google Scholar]
  14. Shields M. B. The non-contact tonometer. Its value and limitations. Surv Ophthalmol. 1980 Jan-Feb;24(4):211–219. doi: 10.1016/0039-6257(80)90042-9. [DOI] [PubMed] [Google Scholar]
  15. Siegel M. J., Lee P. Y., Podos S. M., Mittag T. W. Effect of topical pergolide on aqueous dynamics in normal and glaucomatous monkeys. Exp Eye Res. 1987 Feb;44(2):227–233. doi: 10.1016/s0014-4835(87)80007-6. [DOI] [PubMed] [Google Scholar]
  16. Smith S. A., Smith S. E., Lazare R. An increased effect of pilocarpine on the pupil by application of the drug in oil. Br J Ophthalmol. 1978 May;62(5):314–317. doi: 10.1136/bjo.62.5.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zimmerman T. J., Kaufman H. E. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol. 1977 Apr;95(4):601–604. doi: 10.1001/archopht.1977.04450040067008. [DOI] [PubMed] [Google Scholar]
  18. al-Sereiti M. R., Quik R. F., Turner P. The effect of a single oral dose of pergolide on intraocular pressure and pupil diameter. Br J Clin Pharmacol. 1989 Sep;28(3):263–268. doi: 10.1111/j.1365-2125.1989.tb05425.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES